Eagle Global Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-32,744
| Closed | -$360K | – | 429 |
|
|
2017
Q2 | $360K | Sell |
32,744
-28,666
| -47% | -$315K | 0.01% | 270 |
|
|
2017
Q1 | $602K | Hold |
61,410
| – | – | 0.02% | 193 |
|
|
2016
Q4 | $663K | Hold |
61,410
| – | – | 0.02% | 178 |
|
|
2016
Q3 | $629K | Hold |
61,410
| – | – | 0.02% | 178 |
|
|
2016
Q2 | $802K | Hold |
61,410
| – | – | 0.02% | 156 |
|
|
2016
Q1 | $676K | Hold |
61,410
| – | – | 0.02% | 165 |
|
|
2015
Q4 | $565K | Hold |
61,410
| – | – | 0.02% | 196 |
|
|
2015
Q3 | $426K | Hold |
61,410
| – | – | 0.01% | 227 |
|
|
2015
Q2 | $603K | Hold |
61,410
| – | – | 0.02% | 188 |
|
|
2015
Q1 | $544K | Buy |
61,410
+7,810
| +15% | +$69.2K | 0.01% | 182 |
|
|
2014
Q4 | $470K | Buy |
53,600
+13,490
| +34% | +$118K | 0.01% | 203 |
|
|
2014
Q3 | $276K | Buy |
+40,110
| New | +$276K | 0.01% | 268 |
|